NCT05560581 Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy
| NCT ID | NCT05560581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Psychiatric University Hospital, Zurich |
| Condition | Psychiatric Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 94 participants |
| Start Date | 2022-11-07 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 94 participants in total. It began in 2022-11-07 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of this project is to improve waiting periods for specialised psychotherapy. We will apply a brief, smartphone-based self-efficacy training to patients with psychiatric disorders waiting for specialised psychotherapy. Additionally, we will use Ecological Momentary Assessment (EMA) to assess mood, social contacts, and other parameters daily. We will investigate whether the training can improve self-efficacy and related constructs and if it can help reduce stress and waitlist drop-outs during waiting periods. Additionally, we will investigate if the self-efficacy training has a positive effect on motivation and therapeutical relationship regarding the subsequent therapy. After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.
Eligibility Criteria
Inclusion Criteria: * psychiatric disorder * age 18-65 * waiting for psychiatric assessment/treatment (being on waitlist) * sufficient knowledge of the German language * smartphone user * internet access via smartphone * internet access at home (laptop, tablet, or computer) Exclusion Criteria: * current intense psychotherapy * acute suicidality * acute psychotic symptoms * substance addiction
Contact & Investigator
Judith Rohde, MD
PRINCIPAL INVESTIGATOR
Psychiatric University Hospital Zurich, University of Zurich
Frequently Asked Questions
Who can join the NCT05560581 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Psychiatric Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05560581 currently recruiting?
Yes, NCT05560581 is actively recruiting participants. Contact the research team at judith.rohde@uzh.ch for enrollment information.
Where is the NCT05560581 trial being conducted?
This trial is being conducted at Winterthur, Switzerland, Zurich, Switzerland.
Who is sponsoring the NCT05560581 clinical trial?
NCT05560581 is sponsored by Psychiatric University Hospital, Zurich. The principal investigator is Judith Rohde, MD at Psychiatric University Hospital Zurich, University of Zurich. The trial plans to enroll 94 participants.